Interleukin-37 Inhibits Colon Carcinogensis During Chronic Colitis
Inflammatory bowel disease increases the risk of developing colon cancer. Interleukin (IL-) 37 is a fundamental inhibitor of innate immunity by reducing systemic and local inflammation. IL-37 protein is expressed in healthy and diseased bowel and liver tissue. Here, we tested whether transgenic expression of human IL-37 protects IL-10 deficient (IL-10KO) mice from chronic colitis. IL-37tg mice were crossbred with IL-10KO mice. Homozygous IL-10KO/IL-37tg and IL10KO drank 2% dextran sulfate sodium (DSS) in water for 5 days to induce mild colitis. Colon carcinogenesis was triggered by intragastric administration of celecoxib. Endpoints were clinical parameters of colitis, cytokine responses in LPS-stimulated whole blood and explanted colon specimen and qPCR analysis of colon biopsies. Colon inflammation and number of adenoma—carcinoma were analyzed by histology. During the DSS-induction phase IL-10KO and IL-10KO/IL-37tg mice had a similar weight loss due to mild acute colitis. From day 115 there was a significantly improved weight gain in IL-10KO/IL37-tg mice, though colon length was similar. After ex vivo LPS stimulation whole blood of IL-10KO/IL-37tg compared to IL-10KO mice released less IL-6, IL-17, IFNγ, and TNFα and ex vivo colon cultures showed reduced IL-6 production both indicative of reduced inflammatory conditions under the influence of IL-37. Six out of 10 IL-10KO mice developed colon adenoma and carcinoma. Only one adenoma but no carcinoma was detected in colons of IL-10KO/IL-37tg mice. In conclusion, IL-37 transgene expression protects IL-10KO mice from colon carcinogenesis. It remains unclear whether IL-37 has direct tumor suppressing properties.
CITE THIS COLLECTION
REFERENCES
- https://doi.org//10.1016/j.soc.2017.11.003
- https://doi.org//10.1136/gut.48.4.526
- https://doi.org//10.1053/j.gastro.2010.01.058
- https://doi.org//10.3748/wjg.14.4280
- https://doi.org//10.1038/nrd3800
- https://doi.org//10.1002/eji.201545828
- https://doi.org//10.1038/ni.1944
- https://doi.org//10.1073/pnas.1324140111
- https://doi.org//10.1073/pnas.1424626112
- https://doi.org//10.1038/ni.3103
- https://doi.org//10.1016/j.febslet.2004.09.069
- https://doi.org//10.1006/cyto.2002.0873
- https://doi.org//10.1073/pnas.212519099
- https://doi.org//10.1097/MPG.0000000000000387
SHARE
Usage metrics
Read the peer-reviewed publication
AUTHORS (7)
CATEGORIES
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity